By a News Reporter-Staff News Editor at Computer Weekly News -- Researchers detail new data in Percutaneous Coronary Intervention. According to news reporting originating in Stoke On Trent, United Kingdom, by VerticalNews journalists, research stated, “This study aimed to examine the 30-day unplanned readmissions rate, predictors of readmission, causes of readmissions, and clinical impact of readmissions after percutaneous coronary intervention (PCI). Unplanned rehospitalizations following PCI carry significant burden to both patients and the local health care economy and are increasingly considered as an indicator of quality of care.”
The news reporters obtained a quote from the research, “Patients undergoing PCI between 2013 and 2014 in the U.S. Nationwide Readmission Database were included. Incidence, predictors, causes, and cost of 30-day unplanned readmissions were determined. A total of 833,344 patients with PCI were included, of whom 77,982 (9.3%) had an unplanned readmission within 30 days. Length of stay for the index PCI was greater (4.7 vs. 3.9 days) and mean total hospital cost ($23,211 vs. $37,524) was higher for patients who were readmitted compared with those not readmitted. The factors strongly independently associated with readmissions were index hospitalization discharge against medical advice (odds ratio [OR]: 1.91; 95% confidence interval [CI]: 1.65 to 2.22), transfer to short-term hospital for inpatient care (OR: 1.62; 95% CI: 1.38 to 1.90), discharge to carehome (OR: 1.57; 95% CI: 1.51 to 1.64), and chronic kidney disease (OR: 1.50; 95% CI: 1.44 to 1.55). Charlson Comorbidity Index score (OR: 1.28; 95% CI: 1.27 to 1.29) and number of comorbidities (OR: 1.18; 95% CI: 1.17 to 1.18) were independently associated with unplanned readmission. The majority of readmissions were due to noncardiac causes (56.1%). Thirty-day readmissions after PCI are relatively common and relate to baseline comorbidities and place of discharge.”
According to the news reporters, the research concluded: “More than one-half of the readmissions were due to noncardiac causes.”
For more information on this research see: Burden of 30-Day Readmissions After Percutaneous Coronary Intervention in 833,344 Patients in the United States: Predictors, Causes, and Cost Insights From the Nationwide Readmission Database. Jacc-Cardiovascular Interventions , 2018;11(7):665-674. Jacc-Cardiovascular Interventions can be contacted at: Elsevier Science Inc, 360 Park Ave South, New York, NY 10010-1710, USA.
Our news correspondents report that additional information may be obtained by contacting C.S. Kwok, Royal Stoke Univ Hosp, Stoke On Trent, Staffs, United Kingdom. Additional authors for this research include S.V. Rao, J.E. Potts, E. Kontopantelis, M. Rashid, T. Kinnaird, N. Curzen, J. Nolan, R. Bagur and M.A. Mamas.
Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2018, NewsRx LLC
CITATION: (2018-05-02), Findings from C.S. Kwok and Co-Authors in the Area of Percutaneous Coronary Intervention Reported (Burden of 30-Day Readmissions After Percutaneous Coronary Intervention in 833,344 Patients in the United States: Predictors, Causes, and Cost ...), Computer Weekly News, 289, ISSN: 1944-1606, BUTTER® ID: 015593870
From the newsletter Computer Weekly News.
https://www.newsrx.com/Butter/#!Search:a=15593870
This is a NewsRx® article created by NewsRx® and posted by NewsRx®. As proof that we are NewsRx® posting NewsRx® content, we have added a link to this steemit page on our main corporate website. The link is at the bottom left under "site links" at https://www.newsrx.com/NewsRxCorp/.
We have been in business for more than 20 years and our full contact information is available on our main corporate website.
We only upvote our posts after at least one other user has upvoted the article to increase the curation awards of upvoters.
NewsRx® offers 195 weekly newsletters providing comprehensive information on all professional topics, ranging from health, pharma and life science to business, tech, energy, law, and finance. Our newsletters report only the most relevant and authoritative information from qualified sources.